Written question asked by Chris Green (Conservative) on Thursday, 8 December 2022, in the House of Commons. It was due for an answer on Monday, 12 December 2022. It was answered by Helen Whately (Conservative) on Friday, 16 December 2022 on behalf of the Department of Health and Social Care.
Atrial Fibrillation: Drugs
- Question
-
To ask the Secretary of State for Health and Social Care, whether his Department has plans to undertake an assessment of the impact of the NHS Framework Agreement on Direct Oral Anticoagulants to treat atrial fibrillation, implemented from January 2022.
- Answer
-
Information on the number of new patients detected with atrial fibrillation is not collected in the format requested. As of October 2022, 126,000 patients on general practitioner practice atrial fibrillation registers who were eligible for anticoagulation received treatment. The proportion of patients treated with anticoagulation increased by 3% from April to October 2022.
An annual evaluation of the National Health Service commissioning guidance and framework agreement for anticoagulation will be made in the first quarter of 2023/24 when the relevant prescribing and performance data is finalised.
Secondary information
- Type
- Written question
- Reference
- 106478
- Session
- 2022-23
- Grouped for answer
- Yes
- Subjects
- Drugs Atrial fibrillation
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-12-16 12:30:50 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/106478
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/106478
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/106478